Skip to content
GridEx Center UK provides in-depth analysis, news, and expe…

TikTok Content Creators Fueling Parallel Trade for Unlicensed Weight-Loss Drug

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Service Response and Material Removal

According to TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company said it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of members, filled with images of slimming results, positive testimonials and detailed instructions for mixing or administering at home.

After moments of joining one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an guidebook and promised delivery within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these groups, messages display dark colored parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind this drug is valid, these online products may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to potentially significant health risks”.

EH
By

Erik Hill

A renewable energy consultant with over 15 years of experience in grid modernization projects across Europe.

GridEx Center UK

Type to search articles.